Chynna Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chynna Huang has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Parameswaran Nair
Division of Respirology, St Joseph’s Healthcare & McMaster University
8 shared publications - Katherine Radford
Firestone Institute for Respiratory Health, St. Joseph’s Healthcare, Hamilton, ON L8N 4A6, Canada
7 shared publications - Manali Mukherjee
Department of Medicine, McMaster University
7 shared publications Melanie Kjarsgaard
Firestone Institute for Respiratory Health Hamilton Ontario Canada
7 shared publications- Anurag Bhalla
Division of Respirology, Department of Medicine, Western University, London, ON, Canada
3 shared publications Kayla Zhang
Firestone Institute for Respiratory Health Hamilton Ontario Canada
3 shared publications
Latest Publications
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , OA1414
Non-T2 cytokines post Benralizumab associate with residual symptoms
Rationale: Despite depletion of blood and sputum eosinophils by benralizumab, a subset of patients remain symptomatic (asthma control questionnaire, ACQ-5≥1.5). Objective: To investigate cytokines associated with residual symptoms post-benralizumab. Method: Sputum was assessed for cytokines (EllaTM,Protein Simple) collected at baseline (V1), after placebo (V3), and 5 injections of benralizumab (V10) in 20 severe asthma patients (11 females, 57±13 years) recruited in a sequential placebo-controlled trial (NCT03470311), previously uncontrolled (ACQ 1.5; sputum eos 3%) on mepolizumab/reslizumab. Results: Benralizumab allowed significant decrease in sputum IL-13 (Fig 1A), but increases in IL-6 and TNFa compared to V1, irrespective of ACQ-5 and fractional exhaled nitric oxide (FENO). At V10, optimal response, marked by ACQ-50.05, Mann-Whitney). Increased IL-18 and decreased IL-15 were observed in PR subgroup that further correlated with ACQ-5 (Fig 1B-C). In PR group, n=4 with no improvement (ACQ,V10:2.1±0.6;V10-V1:+0.5±6) had CT mucus plugging. Conclusions: Residual symptoms despite depleted eosinophils post benralizumab may be associated with non-T2 cytokines linked to inflammasome activation (IL-18), reduced NK cell activation (IL-15), and mucus plugging.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , OA1414
Non-T2 cytokines post Benralizumab associate with residual symptoms
Rationale: Despite depletion of blood and sputum eosinophils by benralizumab, a subset of patients remain symptomatic (asthma control questionnaire, ACQ-5≥1.5). Objective: To investigate cytokines associated with residual symptoms post-benralizumab. Method: Sputum was assessed for cytokines (EllaTM,Protein Simple) collected at baseline (V1), after placebo (V3), and 5 injections of benralizumab (V10) in 20 severe asthma patients (11 females, 57±13 years) recruited in a sequential placebo-controlled trial (NCT03470311), previously uncontrolled (ACQ 1.5; sputum eos 3%) on mepolizumab/reslizumab. Results: Benralizumab allowed significant decrease in sputum IL-13 (Fig 1A), but increases in IL-6 and TNFa compared to V1, irrespective of ACQ-5 and fractional exhaled nitric oxide (FENO). At V10, optimal response, marked by ACQ-50.05, Mann-Whitney). Increased IL-18 and decreased IL-15 were observed in PR subgroup that further correlated with ACQ-5 (Fig 1B-C). In PR group, n=4 with no improvement (ACQ,V10:2.1±0.6;V10-V1:+0.5±6) had CT mucus plugging. Conclusions: Residual symptoms despite depleted eosinophils post benralizumab may be associated with non-T2 cytokines linked to inflammasome activation (IL-18), reduced NK cell activation (IL-15), and mucus plugging.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , OA2503
Charcot-Leyden crystals are associated with airway autoimmune responses in severe asthma
Rationale: Airway autoantibodies induce histone-coated eosinophil extracellular traps (EETs). EETs are associated with free eosinophil granules (FEGs) and galectin-10 which autocrystallize ex vivo to form Charcot-Leyden crystals (CLCs). Objective: To investigate cytokines and autoimmune responses in patients with CLCs. Methods: Between 2020-2022, CLCs and cell differentials were routinely reported for processed sputum. Cell-free supernatants were assessed for antinuclear antibodies (HUMAN Diagnostics, PMID 28751233), cytokines (EllaTM, Protein Simple), and danger-associated molecular patterns (DAMPs): high mobility box group 1 (HMGB1) and galectin-10 proteins (Novus Biologicals). Results: CLCs were reported in 61/3075 (2%) processed sputa slides (protocol: PMID 8804934). All 46 CLC+ samples with adequate volume and confirmed severe asthma diagnosis were eosinophilic (≥3% eos±FEGs) and comprised the Eos+CLC+ group. Additionally, Eos+CLC- (n=53) and Eos-CLC- (n=32) were included for analysis. Eos+CLC+ had increased ANAs vs CLC- groups (P+CLC+ (96%) vs. Eos-CLC- (30%) (Fig 1B). Eos+CLC+ had higher T2 inflammation (IL-4, IL-5, IL-13, P- sputa. Conclusions: We report that severe asthma patients with CLCs have high autoimmune burden marked by DAMPs and autoantibodies.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , OA2503
Charcot-Leyden crystals are associated with airway autoimmune responses in severe asthma
Rationale: Airway autoantibodies induce histone-coated eosinophil extracellular traps (EETs). EETs are associated with free eosinophil granules (FEGs) and galectin-10 which autocrystallize ex vivo to form Charcot-Leyden crystals (CLCs). Objective: To investigate cytokines and autoimmune responses in patients with CLCs. Methods: Between 2020-2022, CLCs and cell differentials were routinely reported for processed sputum. Cell-free supernatants were assessed for antinuclear antibodies (HUMAN Diagnostics, PMID 28751233), cytokines (EllaTM, Protein Simple), and danger-associated molecular patterns (DAMPs): high mobility box group 1 (HMGB1) and galectin-10 proteins (Novus Biologicals). Results: CLCs were reported in 61/3075 (2%) processed sputa slides (protocol: PMID 8804934). All 46 CLC+ samples with adequate volume and confirmed severe asthma diagnosis were eosinophilic (≥3% eos±FEGs) and comprised the Eos+CLC+ group. Additionally, Eos+CLC- (n=53) and Eos-CLC- (n=32) were included for analysis. Eos+CLC+ had increased ANAs vs CLC- groups (P+CLC+ (96%) vs. Eos-CLC- (30%) (Fig 1B). Eos+CLC+ had higher T2 inflammation (IL-4, IL-5, IL-13, P- sputa. Conclusions: We report that severe asthma patients with CLCs have high autoimmune burden marked by DAMPs and autoantibodies.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA5294
Assessment of eosinophilic airway inflammation using formalin-fixed, paraffin-embedded sputum plugs
Background: Sputum cytology via clinical dithiothreitol processing is a well-accepted, reproducible method to assess airway eosinophilia (PMID:10673188). However, this multi-step protocol (~1 hour) requires trained personnel and dedicated space, limiting its routine use in clinical practice. Aims: We evaluated the feasibility and validity of using formalin-fixed, paraffin-embedded (FFPE) sputum plugs as a simplified, efficient (~10 min.) method to assess airway eosinophilia. Methods: After clinical processing, excess sputum plugs (~100mg) from 50 patients with airway disease were fixed in 10% formalin overnight, and paraffin embedded. FFPE blocks were sectioned, stained with hematoxylin and eosin, and counted by four observers including two sputum technologists. Mean eosinophil counts were expressed as a percentage of total cells counted and compared with clinical differentials. Results: 48 out of 50 (96%) FFPE sputum plugs were adequate for cell differentials (>400 cells). Eosinophil counts between the two methods were similar (p=0.15, paired t-test, ns), significantly correlated (ρ=0.91, Spearman, P<0.0001) and in agreement (mean/SD on Bland Altman -1.10 7.31). The FFPE method detected airway eosinophilia (AUC ROC 0.95, p2.3%) showed positive anti-eosinophil peroxidase immunostaining. Conclusion: FFPE sputum plugs as a “biopsy tissue block” are feasible for detecting airway eosinophilia, and non-inferior to clinical protocol. Further validation in a healthy cohort is underway.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA5294
Assessment of eosinophilic airway inflammation using formalin-fixed, paraffin-embedded sputum plugs
Background: Sputum cytology via clinical dithiothreitol processing is a well-accepted, reproducible method to assess airway eosinophilia (PMID:10673188). However, this multi-step protocol (~1 hour) requires trained personnel and dedicated space, limiting its routine use in clinical practice. Aims: We evaluated the feasibility and validity of using formalin-fixed, paraffin-embedded (FFPE) sputum plugs as a simplified, efficient (~10 min.) method to assess airway eosinophilia. Methods: After clinical processing, excess sputum plugs (~100mg) from 50 patients with airway disease were fixed in 10% formalin overnight, and paraffin embedded. FFPE blocks were sectioned, stained with hematoxylin and eosin, and counted by four observers including two sputum technologists. Mean eosinophil counts were expressed as a percentage of total cells counted and compared with clinical differentials. Results: 48 out of 50 (96%) FFPE sputum plugs were adequate for cell differentials (>400 cells). Eosinophil counts between the two methods were similar (p=0.15, paired t-test, ns), significantly correlated (ρ=0.91, Spearman, P<0.0001) and in agreement (mean/SD on Bland Altman -1.10 7.31). The FFPE method detected airway eosinophilia (AUC ROC 0.95, p2.3%) showed positive anti-eosinophil peroxidase immunostaining. Conclusion: FFPE sputum plugs as a “biopsy tissue block” are feasible for detecting airway eosinophilia, and non-inferior to clinical protocol. Further validation in a healthy cohort is underway.
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A1301
Sputum Tryptase in Patients With Moderate to Severe Asthma
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A1301
Sputum Tryptase in Patients With Moderate to Severe Asthma
- Open Access
- 12 January 2022
- Published by Springer Nature in Respiratory Research
- Vol. 23 (1) , 1-9
Iron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease
Background: Excess pulmonary iron has been implicated in the pathogenesis of lung disease, including asthma and COPD. An association between higher iron content in sputum macrophages and infective exacerbations of COPD has previously been demonstrated. Objectives: To assess the mechanisms of pulmonary macrophage iron sequestration, test the effect of macrophage iron-loading on cellular immune function, and prospectively determine if sputum hemosiderin index can predict infectious exacerbations of COPD. Methods: Intra- and extracellular iron was measured in cell-line-derived and in freshly isolated sputum macrophages under various experimental conditions including treatment with exogenous IL-6 and hepcidin. Bacterial uptake and killing were compared in the presence or absence of iron-loading. A prospective cohort of COPD patients with defined sputum hemosiderin indices were monitored to determine the annual rate of severe infectious exacerbations. Results: Gene expression studies suggest that airway macrophages have the requisite apparatus of the hepcidin-ferroportin axis. IL-6 and hepcidin play roles in pulmonary iron sequestration, though IL-6 appears to exert its effect via a hepcidin-independent mechanism. Iron-loaded macrophages had reduced uptake of COPD-relevant organisms and were associated with higher growth rates. Infectious exacerbations were predicted by sputum hemosiderin index (β = 0.035, p = 0.035). Conclusions: We demonstrate in-vitro and population-level evidence that excess iron in pulmonary macrophages may contribute to recurrent airway infection in COPD. Specifically, IL-6-dependent iron sequestration by sputum macrophages may result in immune cell dysfunction and ultimately lead to increased frequency of infective exacerbation.
- 12 January 2022
- Published by Springer Nature in Respiratory Research
- Vol. 23 (1) , 1-9
Open AccessIron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease
Background: Excess pulmonary iron has been implicated in the pathogenesis of lung disease, including asthma and COPD. An association between higher iron content in sputum macrophages and infective exacerbations of COPD has previously been demonstrated. Objectives: To assess the mechanisms of pulmonary macrophage iron sequestration, test the effect of macrophage iron-loading on cellular immune function, and prospectively determine if sputum hemosiderin index can predict infectious exacerbations of COPD. Methods: Intra- and extracellular iron was measured in cell-line-derived and in freshly isolated sputum macrophages under various experimental conditions including treatment with exogenous IL-6 and hepcidin. Bacterial uptake and killing were compared in the presence or absence of iron-loading. A prospective cohort of COPD patients with defined sputum hemosiderin indices were monitored to determine the annual rate of severe infectious exacerbations. Results: Gene expression studies suggest that airway macrophages have the requisite apparatus of the hepcidin-ferroportin axis. IL-6 and hepcidin play roles in pulmonary iron sequestration, though IL-6 appears to exert its effect via a hepcidin-independent mechanism. Iron-loaded macrophages had reduced uptake of COPD-relevant organisms and were associated with higher growth rates. Infectious exacerbations were predicted by sputum hemosiderin index (β = 0.035, p = 0.035). Conclusions: We demonstrate in-vitro and population-level evidence that excess iron in pulmonary macrophages may contribute to recurrent airway infection in COPD. Specifically, IL-6-dependent iron sequestration by sputum macrophages may result in immune cell dysfunction and ultimately lead to increased frequency of infective exacerbation.
- Open Access
- 1 February 2019
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 143 (2) , AB1
Sex Differences in Type 2 Innate Lymphoid Cells in Adult Asthmatics
- 1 February 2019
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 143 (2) , AB1
Open AccessSex Differences in Type 2 Innate Lymphoid Cells in Adult Asthmatics
- Top Cited Papers
- 1 January 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 137 (1) , 75-86.e8
Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia
- 1 January 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 137 (1) , 75-86.e8
Top Cited PapersIncreased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia